External validation of novel magnetic resonance imaging-based models for prostate cancer prediction.
Lukas PüllenJan P RadtkeManuel WiesenfarthMonique J RoobolJan F M VerbeekAxel WetterNika GuberinaAbhishek PandeyClemens HüttenbrinkStephan TschirdewahnSascha PahernikBoris A HadaschikFlorian A DistlerPublished in: BJU international (2019)
In our external validation of three novel prostate cancer risk models, which incorporate mpMRI findings, a head-to-head comparison indicated that the MRI-ERSPC-3/4 risk model in particular could help to reduce unnecessary biopsies.